VRDN – viridian therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Viridian Therapeutics (NASDAQ:VRDN) was given a new $47.00 price target on by analysts at William Blair.
Viridian Therapeutics (NASDAQ:VRDN) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
Viridian Therapeutics (NASDAQ:VRDN) was given a new $41.00 price target on by analysts at Truist Financial Corporation.
Viridian Therapeutics (NASDAQ:VRDN) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.
Form SCHEDULE 13G/A Viridian Therapeutics, Filed by: Commodore Capital LP
Form 10-Q Viridian Therapeutics, For: Sep 30
Form 8-K Viridian Therapeutics, For: Nov 05
Form SCHEDULE 13D/A Viridian Therapeutics, Filed by: Fairmount Funds Management LLC
Form 4 Viridian Therapeutics, For: Oct 23 Filed by: Fairmount Healthcare Fund II GP LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.